Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin F Hartley

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmaceutical Statistics|July 29, 2024
Efficient Study Design and Analysis of Longitudinal Dose-Response Data Using Fractional PolynomialsBenjamin F Hartley, Dave Lunn, Adrian P Mander
Biometrical Journal. Biometrische Zeitschrift|October 7, 2025
Multivariate Bayesian Dynamic Borrowing for Repeated Measures Data With Application to External Control Arms in Open-Label Extension StudiesBenjamin F Hartley, Matthew A Psioda, Adrian P Mander
The Lancet. Respiratory Medicine|January 28, 2014
Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trialHenrik Watz, Helen Barnacle, Benjamin F Hartley, et al.
Pharmaceutical Statistics|June 17, 2014
Missing data sensitivity analysis for recurrent event data using controlled imputationOliver N Keene, James H Roger, Benjamin F Hartley, et al.
Respiratory Research|January 8, 2020
Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysisBenjamin F Hartley, Neil C Barnes, Sally Lettis, et al.
Annals of the American Thoracic Society|March 11, 2014
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthmaLynn E Katz, Gerald J Gleich, Benjamin F Hartley, et al.
Statistics in Medicine|February 14, 2025
Using Win Odds to Improve Commit-to-Phase-3 Decision-Making in OncologyBenjamin F Hartley, Thomas Drury, Brian Di Pace, et al.
American Journal of Respiratory and Critical Care Medicine|September 23, 2020
Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic ReviewBartolome R Celli, Julie A Anderson, Nicholas J Cowans, et al.
American Journal of Respiratory and Critical Care Medicine|February 15, 2018
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical TrialKen M Kunisaki, Mark T Dransfield, Julie A Anderson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmaceutical Statistics|July 29, 2024
Efficient Study Design and Analysis of Longitudinal Dose-Response Data Using Fractional PolynomialsBenjamin F Hartley, Dave Lunn, Adrian P Mander
Biometrical Journal. Biometrische Zeitschrift|October 7, 2025
Multivariate Bayesian Dynamic Borrowing for Repeated Measures Data With Application to External Control Arms in Open-Label Extension StudiesBenjamin F Hartley, Matthew A Psioda, Adrian P Mander
The Lancet. Respiratory Medicine|January 28, 2014
Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trialHenrik Watz, Helen Barnacle, Benjamin F Hartley, et al.
Pharmaceutical Statistics|June 17, 2014
Missing data sensitivity analysis for recurrent event data using controlled imputationOliver N Keene, James H Roger, Benjamin F Hartley, et al.
Respiratory Research|January 8, 2020
Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysisBenjamin F Hartley, Neil C Barnes, Sally Lettis, et al.
Annals of the American Thoracic Society|March 11, 2014
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthmaLynn E Katz, Gerald J Gleich, Benjamin F Hartley, et al.
Statistics in Medicine|February 14, 2025
Using Win Odds to Improve Commit-to-Phase-3 Decision-Making in OncologyBenjamin F Hartley, Thomas Drury, Brian Di Pace, et al.
American Journal of Respiratory and Critical Care Medicine|September 23, 2020
Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic ReviewBartolome R Celli, Julie A Anderson, Nicholas J Cowans, et al.
American Journal of Respiratory and Critical Care Medicine|February 15, 2018
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical TrialKen M Kunisaki, Mark T Dransfield, Julie A Anderson, et al.
Pageof 1